Probiotics Market Set to Reach 221.4 Billion by 2032

Rising clinical validation, premiumization and digital commerce are reshaping probiotics into a higher-value, therapy-adjacent category. Consolidation among global leaders will intensify competition on patented strains, adherence-focused formats and multichannel reach, strengthening long-term revenue visibility across human and animal health applications.